Role of phosphoinositide 3-kinases in regulating cardiac function

Frontiers in Bioscience

Volumn 14, Issue 6, 2009, Pages 2221-2229

  Pretorius, Lynette ^a,b   Owen, Kate L ^a,c   McMullen, Julie R ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cardiac hypertrophy; Heart failure; PI3K; Review

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE;

ENZYMOLOGY; HEART; HEART FAILURE; HEART MUSCLE; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; HEART; HEART FAILURE; HUMANS; MYOCARDIUM; SIGNAL TRANSDUCTION;

EID: 63849322493     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3374     Document Type: Article

References (81)

1. AIHW: Heart, stroke and vascular diseases - Australian facts 2004. A report from the Heart Foundation and the Australian Institute of Health and Welfare. Cardiovascular Disease Series, 22, 1-152 (2004).
2. Thom, T., N. Haase, W. Rosamond, V.J. Howard, J. Rumsfeld, T. Manolio, Z.J. Zheng, K. Flegal, C. O'Donnell, S. Kittner, D. Lloyd-Jones, D.C. Goff, Jr., Y. Hong, R. Adams, G. Friday, K. Furie, P. Gorelick, B. Kissela, J. Marler, J. Meigs, V. Roger, S. Sidney, P. Sorlie, J. Steinberger, S. Wasserthiel-Smoller, M. Wilson, P. Wolf, C. American Heart Association Statistics & S. Stroke Statistics: Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 113, 14 (2006).
3. CDC: Health, United States, with chartbook on trends in the health of Americans. Centers for Disease Control and Prevention & National Center for Health Statistics (2006).
4. Fruman, D.A., R.E. Meyers & L.C. Cantley: Phosphoinositide kinases. Annual Review of Biochemistry, 67, 481-507 (1998). (Pubitemid 28411136)
5. Vanhaesebroeck, B., S.J. Leevers, G. Panayotou & M.D. Waterfield: Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends in Biochemical Sciences, 22, 267-72 (1997). (Pubitemid 27310948)
6. Vanhaesebroeck, B. & M.D. Waterfield: Signaling by distinct classes of phosphoinositide 3-kinases. Experimental Cell Research, 253, 239-54 (1999).
7. Crackower, M.A., G.Y. Oudit, I. Kozieradzki, R. Sarao, H. Sun, T. Sasaki, E. Hirsch, A. Suzuki, T. Shioi, J. Irie-Sasaki, R. Sah, H.Y. Cheng, V.O. Rybin, G. Lembo, L. Fratta, A.J. Oliveira-dos-Santos, J.L. Benovic, C.R. Kahn, S. Izumo, S.F. Steinberg, M.P. Wymann, P.H. Backx & J.M. Penninger: Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell, 110, 737-49 (2002). (Pubitemid 35283963)
8. Northcott, C.A., M.N. Poy, S.M. Najjar & S.W. Watts: Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circulation Research, 91, 360-9 (2002). (Pubitemid 34977003)
9. Bacqueville, D., P. Deleris, C. Mendre, M.T. Pieraggi, H. Chap, G. Guillon, B. Perret & M. Breton-Douillon: Characterization of a G protein-activated phosphoinositide 3-kinase in vascular smooth muscle cell nuclei. Journal of Biological Chemistry, 276, 22170-6 (2001).
10. Quignard, J.F., J. Mironneau, V. Carricaburu, B. Fournier, A. Babich, B. Nurnberg, C. Mironneau & N. Macrez: Phosphoinositide 3-kinase gamma mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes. Journal of Biological Chemistry, 276, 32545-51 (2001).
11. Oudit, G.Y., H. Sun, B.G. Kerfant, M.A. Crackower, J.M. Penninger & P.H. Backx: The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. Journal of Molecular & Cellular Cardiology, 37, 449-71 (2004). (Pubitemid 38953373)
12. Hawkins, P.T., K.E. Anderson, K. Davidson & L.R. Stephens: Signalling through Class I PI3Ks in mammalian cells. Biochemical Society Transactions, 34, 647-62 (2006). (Pubitemid 44796393)
13. Adams, T.E., V.C. Epa, T.P. Garrett & C.W. Ward: Structure and function of the type 1 insulin-like growth factor receptor. Cellular & Molecular Life Sciences, 57, 1050-93 (2000). (Pubitemid 30598754)
14. Andrews, S., L.R. Stephens & P.T. Hawkins: PI3K class IB pathway. Science's Stke [Electronic Resource]: Signal Transduction Knowledge Environment, 2007, cm2 (2007).
15. Naga Prasad, S.V., G. Esposito, L. Mao, W.J. Koch & H.A. Rockman: Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. Journal of Biological Chemistry, 275, 4693-8 (2000). (Pubitemid 30108856)
16. Otani, H., T. Yamamura, Y. Nakao, R. Hattori, H. Kawaguchi, M. Osako & H. Imamura: Insulin-like growth factor-I improves recovery of cardiac performance during reperfusion in isolated rat heart by a wortmannin-sensitive mechanism. Journal of Cardiovascular Pharmacology, 35, 275-81 (2000). (Pubitemid 30073820)
17. Mockridge, J.W., M.S. Marber & R.J. Heads: Activation of Akt during simulated ischemia/reperfusion in cardiac myocytes. Biochemical & Biophysical Research Communications, 270, 947-52 (2000). (Pubitemid 30444812)
18. Jo, S.-H., V. Leblais, P.H. Wang, M.T. Crow & R.-P. Xiao: Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation. Circulation Research, 91, 46-53 (2002). (Pubitemid 34778941)
19. Kulik, G., A. Klippel & M.J. Weber: Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Molecular & Cellular Biology, 17, 1595-606 (1997). (Pubitemid 27097389)
20. Sun, H., G.Y. Oudit, R.J. Ramirez, D. Costantini & P.H. Backx: The phosphoinositide 3-kinase inhibitor LY294002 enhances cardiac myocyte contractility via a direct inhibition of Ik, slow currents. Cardiovascular Research, 62, 509-20 (2004). (Pubitemid 38648965)
21. McMullen, J.R. & G.L. Jennings: Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clinical & Experimental Pharmacology & Physiology, 34, 255-62 (2007).
22. McMullen, J.R., T. Shioi, W.Y. Huang, L. Zhang, O. Tarnavski, E. Bisping, M. Schinke, S. Kong, M.C. Sherwood, J. Brown, L. Riggi, P.M. Kang & S. Izumo: The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. Journal of Biological Chemistry, 279, 4782-93 (2004). (Pubitemid 38199073)
23. McMullen, J.R., T. Shioi, L. Zhang, O. Tarnavski, M.C. Sherwood, P.M. Kang & S. Izumo: Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proceedings of the National Academy of Sciences of the United States of America, 100, 12355-60 (2003). (Pubitemid 37271564)
24. Shioi, T., P.M. Kang, P.S. Douglas, J. Hampe, C.M. Yballe, J. Lawitts, L.C. Cantley & S. Izumo: The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO Journal, 19, 2537-48 (2000). (Pubitemid 30323543)
25. Luo, J., J.R. McMullen, C.L. Sobkiw, L. Zhang, A.L. Dorfman, M.C. Sherwood, M.N. Logsdon, J.W. Horner, R.A. DePinho, S. Izumo & L.C. Cantley: Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Molecular & Cellular Biology, 25, 9491-502 (2005). (Pubitemid 41507849)
26. Coleman, M.E., F. DeMayo, K.C. Yin, H.M. Lee, R. Geske, C. Montgomery & R.J. Schwartz: Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. Journal of Biological Chemistry, 270, 12109-16 (1995).
27. Chan, T.O., S.E. Rittenhouse & P.N. Tsichlis: AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annual Review of Biochemistry, 68, 965-1014 (1999). (Pubitemid 29449213)
28. DeBosch, B., I. Treskov, T.S. Lupu, C. Weinheimer, A. Kovacs, M. Courtois & A.J. Muslin: Akt1 is required for physiological cardiac growth. Circulation, 113, 2097-104 (2006).
29. Oudit, G.Y., M.A. Crackower, U. Eriksson, R. Sarao, I. Kozieradzki, T. Sasaki, J. Irie-Sasaki, D. Gidrewicz, V.O. Rybin, T. Wada, S.F. Steinberg, P.H. Backx & J.M. Penninger: Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. Circulation, 108, 2147-52 (2003). (Pubitemid 37337593)
30. Kerfant, B.-G., D. Zhao, I. Lorenzen-Schmidt, L.S. Wilson, S. Cai, S.R.W. Chen, D.H. Maurice & P.H. Backx: PI3Kgamma is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes. Circulation Research, 101, 400-8 (2007). (Pubitemid 47267708)
31. Tasken, K. & E.M. Aandahl: Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiological Reviews, 84, 137-67 (2004). (Pubitemid 38049878)
32. Rose, R.A., M.G. Kabir & P.H. Backx: Altered heart rate and sinoatrial node function in mice lacking the cAMP regulator phosphoinositide 3-kinase-gamma. Circulation Research, 101, 1274-82 (2007). (Pubitemid 350294644)
33. Maltsev, V.A. & E.G. Lakatta: Normal heart rhythm is initiated and regulated by an intracellular calcium clock within pacemaker cells. Heart, Lung & Circulation, 16, 335-48 (2007). (Pubitemid 47504909)
34. Blatter, L.A., J. Kockskamper, K.A. Sheehan, A.V. Zima, J. Huser & S.L. Lipsius: Local calcium gradients during excitation-contraction coupling and alternans in atrial myocytes. Journal of Physiology, 546, 19-31 (2003).
35. Clark, R.A., S. McLennan, A. Dawson, D. Wilkinson & S. Stewart: Uncovering a hidden epidemic: a study of the current burden of heart failure in Australia. Heart, Lung & Circulation, 13, 266-73 (2004). (Pubitemid 39317649)
36. Lilly, L.S.: Pathophysiology of heart disease: a collaborative project of medical students and faculty, 4th Edition. Lippincott Williams & Wilkins, Sydney (2007).
37. McMullen, J.R., J. Sadoshima & S. Izumo: Physiological versus pathological cardiac hypertrophy. In: Molecular Mechanisms of Cardiac Hypertrophy and Failure. Ed: R. A. Walsh. Taylor and Francis Group, London (2005).
38. Chien, K.R., K.U. Knowlton, H. Zhu & S. Chien: Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB Journal, 5, 3037-46 (1991). (Pubitemid 21892863)
39. Adams, J.W., Y. Sakata, M.G. Davis, V.P. Sah, Y. Wang, S.B. Liggett, K.R. Chien, J.H. Brown & G.W. Dorn, 2nd: Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proceedings of the National Academy of Sciences of the United States of America, 95, 10140-5 (1998). (Pubitemid 28415308)
40. Sharma, A.K., S. Dhingra, N. Khaper & P.K. Singal: Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs. American Journal of Physiology - Heart & Circulatory Physiology, 293, H1384-90 (2007). (Pubitemid 47367180)
41. McMullen, J.R., F. Amirahmadi, E.A. Woodcock, M. Schinke-Braun, R.D. Bouwman, K.A. Hewitt, J.P. Mollica, L. Zhang, Y. Zhang, T. Shioi, A. Buerger, S. Izumo, P.Y. Jay & G.L. Jennings: Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America, 104, 612-7 (2007). (Pubitemid 46123073)
42. Crone, S.A., Y.-Y. Zhao, L. Fan, Y. Gu, S. Minamisawa, Y. Liu, K.L. Peterson, J. Chen, R. Kahn, G. Condorelli, J. Ross, Jr., K.R. Chien & K.-F. Lee: ErbB2 is essential in the prevention of dilated cardiomyopathy. Nature Medicine, 8, 459-65 (2002). (Pubitemid 34546747)
43. Ozcelik, C., B. Erdmann, B. Pilz, N. Wettschureck, S. Britsch, N. Hubner, K.R. Chien, C. Birchmeier & A.N. Garratt: Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America, 99, 8880-5 (2002). (Pubitemid 34693652)
44. Dorn, G.W., 2nd, J. Robbins, N. Ball & R.A. Walsh: Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. American Journal of Physiology, 267, H400-5 (1994). (Pubitemid 24239177)
45. del Monte, F., S.E. Harding, U. Schmidt, T. Matsui, Z.B. Kang, G.W. Dec, J.K. Gwathmey, A. Rosenzweig & R.J. Hajjar: Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation, 100, 2308-11 (1999).
46. Izumo, S., B. Nadal-Ginard & V. Mahdavi: Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proceedings of the National Academy of Sciences of the United States of America, 85, 339-43 (1988).
47. Chien, K.R., H. Zhu, K.U. Knowlton, W. Miller-Hance, M. Van-Bilsen, T.X. O'Brien & S.M. Evans: Transcriptional regualtion during cardiac growth and development. Annual Review of Physiology, 55, 77-95 (1993). (Pubitemid 23102124)
48. Nagai, R., A. Zarain-Herzberg, C.J. Brandl, J. Fujii, M. Tada, D.H. MacLennan, N.R. Alpert & M. Periasamy: Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proceedings of the National Academy of Sciences of the United States of America, 86, 2966-70 (1989). (Pubitemid 19112658)
49. Matsui, H., D.H. MacLennan, N.R. Alpert & M. Periasamy: Sarcoplasmic reticulum gene expression in pressure overload-induced cardiac hypertrophy in rabbit. American Journal of Physiology, 268, C252-8 (1995).
50. Arai, M., T. Suzuki & R. Nagai: Sarcoplasmic reticulum genes are upregulated in mild cardiac hypertrophy but downregulated in severe cardiac hypertrophy induced by pressure overload. Journal of Molecular & Cellular Cardiology, 28, 1583-90 (1996). (Pubitemid 26300560)
51. Miyamoto, M.I., F. del Monte, U. Schmidt, T.S. DiSalvo, Z.B. Kang, T. Matsui, J.L. Guerrero, J.K. Gwathmey, A. Rosenzweig & R.J. Hajjar: Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proceedings of the National Academy of Sciences of the United States of America, 97, 793-8 (2000). (Pubitemid 30070389)
52. Schultz, J.E.J., B.J. Glascock, S.A. Witt, M.L. Nieman, K.J. Nattamai, L.H. Liu, J.N. Lorenz, G.E. Shull, T.R. Kimball & M. Periasamy: Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity. American Journal of Physiology - Heart & Circulatory Physiology, 286, H1146-53 (2004). (Pubitemid 38248632)
53. Scheuer, J., A. Malhotra, C. Hirsch, J. Capasso & T.F. Schaible: Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats. Journal of Clinical Investigation, 70, 1300-5 (1982). (Pubitemid 13168011)
54. Pieples, K., G. Arteaga, R.J. Solaro, I. Grupp, J.N. Lorenz, G.P. Boivin, G. Jagatheesan, E. Labitzke, P.P. DeTombe, J.P. Konhilas, T.C. Irving & D.F. Wieczorek: Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca(2+) activation. American Journal of Physiology - Heart & Circulatory Physiology, 283, H1344-53 (2002).
55. Hewett, T.E., I.L. Grupp, G. Grupp & J. Robbins: Alpha-skeletal actin is associated with increased contractility in the mouse heart. Circulation Research, 74, 740-6 (1994).
56. Hart, M.C., Y.O. Korshunova & J.A. Cooper: Vertebrates have conserved capping protein alpha isoforms with specific expression patterns. Cell Motility & the Cytoskeleton, 38, 120-32 (1997). (Pubitemid 27430419)
57. Hart, M.C., Y.O. Korshunova & J.A. Cooper: Mapping of the mouse actin capping protein alpha subunit genes and pseudogenes. Genomics, 39, 264-70 (1997). (Pubitemid 27078692)
58. Littlefield, R., A. Almenar-Queralt & V.M. Fowler: Actin dynamics at pointed ends regulates thin filament length in striated muscle. Nature Cell Biology, 3, 544-51 (2001). (Pubitemid 32536850)
59. Narula, J., N. Haider, R. Virmani, T.G. DiSalvo, F.D. Kolodgie, R.J. Hajjar, U. Schmidt, M.J. Semigran, G.W. Dec & B.A. Khaw: Apoptosis in myocytes in end-stage heart failure. New England Journal of Medicine, 335, 1182-9 (1996). (Pubitemid 26339772)
60. Sharov, V.G., H.N. Sabbah, H. Shimoyama, A.V. Goussev, M. Lesch & S. Goldstein: Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. American Journal of Pathology, 148, 141-9 (1996). (Pubitemid 26019652)
61. Di Napoli, P., A.A. Taccardi, A. Grilli, M. Felaco, A. Balbone, D. Angelucci, S. Gallina, A.M. Calafiore, R. De Caterina & A. Barsotti: Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy. American Heart Journal, 146, 1105-11 (2003). (Pubitemid 37500789)
62. Yao, R. & G.M. Cooper: Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science, 267, 2003-6 (1995).
63. Crowder, R.J. & R.S. Freeman: Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. Journal of Neuroscience, 18, 2933-43 (1998). (Pubitemid 28163223)
64. Lee, W.L., J.W. Chen, C.T. Ting, T. Ishiwata, S.J. Lin, M. Korc & P.H. Wang: Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy. Endocrinology, 140, 4831-40 (1999). (Pubitemid 30666153)
65. Li, Q., B. Li, X. Wang, A. Leri, K.P. Jana, Y. Liu, J. Kajstura, R. Baserga & P. Anversa: Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. Journal of Clinical Investigation, 100, 1991-9 (1997). (Pubitemid 27459352)
66. Datta, S.R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh & M.E. Greenberg: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-41 (1997). (Pubitemid 27456390)
67. Cardone, M.H., N. Roy, H.R. Stennicke, G.S. Salvesen, T.F. Franke, E. Stanbridge, S. Frisch & J.C. Reed: Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-21 (1998). (Pubitemid 28524494)
68. Kuwahara, K., Y. Saito, I. Kishimoto, Y. Miyamoto, M. Harada, E. Ogawa, I. Hamanaka, N. Kajiyama, N. Takahashi, T. Izumi, R. Kawakami & K. Nakao: Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes. Journal of Molecular & Cellular Cardiology, 32, 1385-94 (2000).
69. Dhanasekaran, A., S.K. Gruenloh, J.N. Buonaccorsi, R. Zhang, G.J. Gross, J.R. Falck, P.K. Patel, E.R. Jacobs & M. Medhora: Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. American Journal of Physiology - Heart & Circulatory Physiology, 294, H724-35 (2008). (Pubitemid 351253284)
70. Cook, S.A., P.H. Sugden & A. Clerk: Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circulation Research, 85, 940-9 (1999). (Pubitemid 29534169)
71. Deveraux, Q.L., R. Takahashi, G.S. Salvesen & J.C. Reed: X-linked IAP is a direct inhibitor of cell-death proteases. Nature, 388, 300-4 (1997). (Pubitemid 27317977)
72. Bakth, S., J. Arena, W. Lee, R. Torres, B. Haider, B.C. Patel, M.M. Lyons & T.J. Regan: Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioning. Journal of Clinical Investigation, 77, 382-95 (1986). (Pubitemid 16037636)
73. Merx, W., M.S. Yoon & J. Han: The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. American Heart Journal, 94, 603-10 (1977). (Pubitemid 8223535)
74. Jalil, J.E., C.W. Doering, J.S. Janicki, R. Pick, S.G. Shroff & K.T. Weber: Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circulation Research, 64, 1041-50 (1989). (Pubitemid 19155774)
75. Perrino, C., J.N. Schroder, B. Lima, N. Villamizar, J.J. Nienaber, C.A. Milano & S.V. Naga Prasad: Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure. Circulation, 116, 2571-9 (2007).
76. Bristow, M.R., R. Ginsburg, W. Minobe, R.S. Cubicciotti, W.S. Sageman, K. Lurie, M.E. Billingham, D.C. Harrison & E.B. Stinson: Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. New England Journal of Medicine, 307, 205-11 (1982). (Pubitemid 12079105)
77. Naga Prasad, S.V., L.S. Barak, A. Rapacciuolo, M.G. Caron & H.A. Rockman: Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by betaadrenergic receptor kinase 1. A role in receptor sequestration. Journal of Biological Chemistry, 276, 18953-9 (2001).
78. Perrino, C., S.V. Naga Prasad, J.N. Schroder, J.A. Hata, C. Milano & H.A. Rockman: Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex. Circulation, 111, 2579-87 (2005). (Pubitemid 40740856)
79. Nienaber, J.J., H. Tachibana, S.V. Naga Prasad, G. Esposito, D. Wu, L. Mao & H.A. Rockman: Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure. Journal of Clinical Investigation, 112, 1067-79 (2003). (Pubitemid 38056322)
80. Oudit, G.Y. & Z. Kassiri: Role of PI3 kinase gamma in excitation-contraction coupling and heart disease. Cardiovascular & Hematological Disorders Drug Targets, 7, 295-304 (2007). (Pubitemid 350302904)
81. Patrucco, E., A. Notte, L. Barberis, G. Selvetella, A. Maffei, M. Brancaccio, S. Marengo, G. Russo, O. Azzolino, S.D. Rybalkin, L. Silengo, F. Altruda, R. Wetzker, M.P. Wymann, G. Lembo & E. Hirsch: PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and - independent effects. Cell, 118, 375-87 (2004). (Pubitemid 39061117)